Mohammed Baqur S Al-Shuhaib | Composite Material | Best Researcher Award

Mohammed Baqur S Al-Shuhaib| Composite Material | Best Researcher Award

Prof. Mohammed Baqur S Al-Shuhaib , Al-Qasim Green University , Iraq.

🎓 Prof. Mohammed Baqur S. Al-Shuhaib is a distinguished Professor of Molecular Genetics and Bioinformatics at Al-Qasim Green University, Iraq. 🌍 He is known for his expertise in molecular genetics, bioinformatics, and composite material research. 🧬 His work emphasizes the genetic and molecular modeling of composite materials, exploring their interactions and applications in biomedical and agricultural sciences. 📚 With an impressive record of SCOPUS-indexed publications, Prof. Al-Shuhaib is a prominent academic figure contributing significantly to the advancement of materials science and genetics. 📈

Publication Profile

Scopus
Orcid
Google Scholar

Education and Experience

  • 🎓 B.Sc. in Biology, University of Babylon
  • 🎓 M.Sc. in Biotechnology (Molecular Genetics), Baghdad University
  • 🎓 Ph.D. in Molecular Genetics, University of Babylon
  • 🧪 Membership (2011): Nucleic Acids Research Center, Babylon University
  • 🏫 Assistant Dean (2012): College of Biotechnology, Al-Qasim Green University
  • 🧬 Chairman (2013-2014): Department of Genetic Engineering, College of Biotechnology
  • 🐄 Academic Member (2014-present): Department of Animal Production, College of Agriculture

Suitability Summary

Prof.Mohammed Baqur S Al-Shuhaib has been a member of several prestigious academic and research bodies, including the Nucleic Acids Research Center at Babylon University and the Department of Animal Production at Al-Qasim Green University. He has published numerous papers indexed in Scopus, contributing valuable knowledge to the scientific community. His academic leadership and research accomplishments position him as a leading candidate for the Best Researcher Award. His work has not only advanced the field of molecular genetics but has also had practical applications in both human health and agriculture, highlighting his broad impact and recognition in the scientific community. Prof. Al-Shuhaib’s work exemplifies the highest standards of research excellence and innovation.

Professional Development

Mohamed Maher | Material Science | Impactful Research Award

Mohamed Maher | Material Science | Impactful Research Award

Dr. Mohamed Maher, University of Texas Southwestern Medical Center, United States.

Publication profile

Scopus

Education and Experience

Education 🎓
  • Ph.D. in Cancer Biology (Molecular Virology and Immunology) – National Cancer Institute, Cairo University, Egypt (2011–2017)
  • M.Sc. in Pharmaceutical Sciences (Microbiology and Immunology) – Assiut University, Egypt (2006–2010)
  • B.Sc. in Pharmaceutical Sciences – Assiut University, Egypt (1998–2003)
Experience 💼
  • Senior Research Assistant – MD Anderson Cancer Center, Houston, TX (2022–Present)
  • Postdoctoral Fellow – MD Anderson Cancer Center, Houston, TX (2019–2022)
  • Lecturer of Cancer Biology, Virology, and Immunology – South Egypt Cancer Institute, Assiut University, Egypt (2017–Present)
  • Assistant Lecturer – South Egypt Cancer Institute, Assiut University, Egypt (2015–2017)

Suitability For The Award

Dr. Mohamed Maher stands as a distinguished cancer researcher whose transformative contributions to molecular diagnostics and cancer genomics make him an ideal candidate for the prestigious Impactful Research Award. His innovative work in cancer genotyping, particularly in liquid biopsies, solid tumors, and hematological malignancies, underscores his dedication to advancing diagnostic precision and improving patient outcomes. Dr. Maher’s expertise, blending his background as a Clinical Pharmacist, Cancer Biologist, and Molecular Diagnostic innovator, highlights his remarkable ability to translate cutting-edge research into real-world clinical applications, creating a lasting impact in cancer research and diagnostics.

Professional Development 

Publications Top Notes

  • “A rapid turnaround time workflow for a cytological liquid biopsy assay using FNA supernatant specimens” (Maher, M.H., et al., 2025, Cancer Cytopathology) – 📅 2025 | 🔗 Open Access | ✨ 
  • “Dinutuximab synergistically enhances the cytotoxicity of natural killer cells to retinoblastoma through the perforin-granzyme B pathway” (Wang, H., et al., 2020, OncoTargets and Therapy) – 📅 2020 | 🔗 8 Citations